Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-07
DOI
10.1186/s13195-020-00607-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial
- (2019) David Fitchett et al. CIRCULATION
- A Close Look at BACE1 Inhibitors for Alzheimer’s Disease Treatment
- (2019) Brati Das et al. CNS DRUGS
- γ-Secretase and its modulators: Twenty years and beyond
- (2019) Weiming Xia NEUROSCIENCE LETTERS
- Leptin in hippocampus mediates benefits of mild exercise by an antioxidant on neurogenesis and memory
- (2019) Jang Soo Yook et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Outcomes and clinical implications of intranasal insulin administration to the central nervous system
- (2019) João C.P. Santiago et al. EXPERIMENTAL NEUROLOGY
- Role of liraglutide in brain repair promotion through Sirt1‐mediated mitochondrial improvement in stroke
- (2019) Weiliang He et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus
- (2018) Hussein Al Jobori et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Liraglutide Protects Neurite Outgrowth of Cortical Neurons Under Oxidative Stress though Activating the Wnt Pathway
- (2018) Weiliang He et al. Journal of Stroke & Cerebrovascular Diseases
- Cardiovascular Mortality Reduction With Empagliflozin in Patients With Type 2 Diabetes and Cardiovascular Disease
- (2018) David Fitchett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
- (2018) Geert Jan Biessels et al. Nature Reviews Endocrinology
- Mutual relationship between Tau and central insulin signalling: consequences for AD and Tauopathies ?
- (2018) Maud Gratuze et al. NEUROENDOCRINOLOGY
- Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab
- (2018) Enchi Liu et al. NEUROLOGY
- Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models
- (2018) Christian Hölscher NEUROPHARMACOLOGY
- Liraglutide Protects Neurite Outgrowth of Cortical Neurons Under Oxidative Stress though Activating the Wnt Pathway
- (2018) Weiliang He et al. Journal of Stroke & Cerebrovascular Diseases
- Increases in circulating levels of ketone bodies and cardiovascular protection with SGLT2 inhibitors: Is low-grade inflammation the neglected component?
- (2018) Francesco Prattichizzo et al. DIABETES OBESITY & METABOLISM
- Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control
- (2018) Silvio E. Inzucchi et al. CIRCULATION
- Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer’s and Parkinson’s Diseases
- (2018) Andre F. Batista et al. CNS DRUGS
- Diabetes and Alzheimer’s Disease: A Link not as Simple as it Seems
- (2018) Isabel H. Salas et al. NEUROCHEMICAL RESEARCH
- Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology
- (2018) Martina Holubová et al. NEUROPHARMACOLOGY
- Chronic social stress-induced hyperglycemia in mice couples individual stress susceptibility to impaired spatial memory
- (2018) Michael A. van der Kooij et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Interaction of Anti-Diabetic Drugs With Acetylcholinesterase and Sodium Glucose Co-Transporter 2
- (2017) Shazi Shakil JOURNAL OF CELLULAR BIOCHEMISTRY
- Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic mice
- (2017) Paul Millar et al. JOURNAL OF ENDOCRINOLOGY
- Vaccination strategies in tauopathies and synucleinopathies
- (2017) Anne K. Braczynski et al. JOURNAL OF NEUROCHEMISTRY
- Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer’s Disease and Type 2 Diabetes
- (2017) Carmen Infante-Garcia et al. MOLECULAR NEUROBIOLOGY
- The Association Between the Dosage of SGLT2 Inhibitor and Weight Reduction in Type 2 Diabetes Patients: A Meta-Analysis
- (2017) Xiaoling Cai et al. Obesity
- SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats
- (2017) Piangkwan Sa-nguanmoo et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
- (2017) Sebastian Steven et al. Redox Biology
- Pioglitazone prevents tau oligomerization
- (2016) Tadanori Hamano et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders
- (2016) Sibhghatulla Shaikh et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Association Between Diabetes and Hippocampal Atrophy in Elderly Japanese: The Hisayama Study
- (2016) Naoki Hirabayashi et al. DIABETES CARE
- The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin
- (2016) Matthias Kern et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer’s disease and type 2 diabetes
- (2016) Carmen Infante-Garcia et al. PSYCHONEUROENDOCRINOLOGY
- Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus
- (2015) Ian J Neeland et al. Diabetes & Vascular Disease Research
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease
- (2015) Juan Jose Ramos-Rodriguez et al. PSYCHONEUROENDOCRINOLOGY
- The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease
- (2014) Christian Hölscher Alzheimers & Dementia
- Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
- (2014) Bowen Lin et al. Cardiovascular Diabetology
- Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease
- (2014) F. G. De Felice et al. DIABETES
- Glucocorticoid receptor activation impairs hippocampal plasticity by suppressing BDNF expression in obese mice
- (2014) Marlena Wosiski-Kuhn et al. PSYCHONEUROENDOCRINOLOGY
- Update on developments with SGLT2 inhibitors in the management of type 2 diabetes
- (2014) Michael Nauck Drug Design Development and Therapy
- Obesity and diabetes cause cognitive dysfunction in the absence of accelerated β-amyloid deposition in a novel murine model of mixed or vascular dementia
- (2014) Dana M Niedowicz et al. Acta Neuropathologica Communications
- Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice
- (2013) Juan Jose Ramos-Rodriguez et al. PSYCHONEUROENDOCRINOLOGY
- Liraglutide, a Long-Acting GLP-1 Mimetic, and its Metabolite Attenuate Inflammation after Intracerebral Hemorrhage
- (2012) Jack Hou et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice
- (2011) Mikko Hiltunen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and A deposition in an Alzheimer mouse model with diabetes
- (2010) S. Takeda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now